These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7854995)
21. How to stop the allergy march. Lopes Dos Santos JM Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):39-40. PubMed ID: 17761107 [No Abstract] [Full Text] [Related]
23. Cutaneous adverse drug reactions seen at a university hospital department of dermatology. Borch JE; Andersen KE; Bindslev-Jensen C Acta Derm Venereol; 2006; 86(6):523-7. PubMed ID: 17106600 [TBL] [Abstract][Full Text] [Related]
24. Severe adverse reactions during specific subcutaneous immunotherapy. Ricciardi L; Isola S; Gangemi S; Cilia M; Levanti C; D'Ambrosio FP Allergy; 1996 Jan; 51(1):62. PubMed ID: 8721532 [No Abstract] [Full Text] [Related]
25. [Hyposensitizing therapy in an atopic form of bronchial asthma]. Matkova KP; Silkina AG; Belous VM Vrach Delo; 1977 Sep; (9):60-1. PubMed ID: 919485 [No Abstract] [Full Text] [Related]
26. Adverse food reactions in patients with grass pollen allergic respiratory disease. Boccafogli A; Vicentini L; Camerani A; Cogliati P; D'Ambrosi A; Scolozzi R Ann Allergy; 1994 Oct; 73(4):301-8. PubMed ID: 7943997 [TBL] [Abstract][Full Text] [Related]
27. Anaphylactic reactions during immunotherapy. Rezvani M; Bernstein DI Immunol Allergy Clin North Am; 2007 May; 27(2):295-307, viii. PubMed ID: 17493504 [TBL] [Abstract][Full Text] [Related]
28. Parameters of immunotherapy: a retrospective study. Malet A; Lluch M; Valero A; Amat P Allergol Immunopathol (Madr); 1993; 21(1):7-10. PubMed ID: 8328357 [TBL] [Abstract][Full Text] [Related]
29. Serum tryptase in allergic rhinitis: effect of cetirizine and fluticasone propionate treatment. Bruno G; Andreozzi P; Bracchitta S; Graf U; Santangelo G; Zaino S; Gaston N Clin Ter; 2001; 152(5):299-303. PubMed ID: 11794849 [TBL] [Abstract][Full Text] [Related]
30. [Cetirizine and respiratory tract infections in opinion of Polish doctors]. Jahnz-Rózyk K Pol Merkur Lekarski; 2006 Nov; 21(125):454-8. PubMed ID: 17345839 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of specific immunotherapy to mosquito bites. Ariano R; Panzani RC Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):131-8. PubMed ID: 15180354 [TBL] [Abstract][Full Text] [Related]
33. Double-blind placebo controlled specific immunotherapy with mixed Cupressaceae taxodiaceae pollens in respiratory allergy to Cupressus sempervirens. Ariano R; Panzani RC; Augeri G Allergol Immunopathol (Madr); 1997; 25(1):23-9. PubMed ID: 9111873 [TBL] [Abstract][Full Text] [Related]
34. [Specific desensitizing therapy in the treatment of respiratory allergic diseases]. Noferi A; Ferrante E; Testa A Folia Allergol (Roma); 1966; 13(4):280-9. PubMed ID: 5990235 [No Abstract] [Full Text] [Related]
35. [Specific and nonspecific hyposensitization of animals with experimental allergy to the antigen from Dermatophagoides pteronyssinus mites]. Ivanov LN Patol Fiziol Eksp Ter; 1979; (1):44-8. PubMed ID: 424244 [No Abstract] [Full Text] [Related]
36. [Long-term tolerance of specific hyposensitization with the aid of calcium phosphate-adsorbed mite extracts]. Lelong M; Miersman R Allerg Immunol (Paris); 1986 Nov; 18(9):15-6, 18. PubMed ID: 2456078 [TBL] [Abstract][Full Text] [Related]